Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (941-950 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Cancer Discovery|June 3, 2024
When Lightning Strikes Twice: Routes to Second Malignancies in Young PatientsClarissa N Pacyna, Jyoti Nangalia
Cancer Discovery|June 13, 2024
Tumor Promoters and Opportunities for Molecular Cancer PreventionWilliam Hill, Clare E Weeden, Charles Swanton
Cancer Discovery|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer EvolutionIros Barozzi, Neil Slaven, Eleonora Canale, et al.
Cancer Discovery|April 24, 2024
Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene ExpressionYiman Liu, Qinglan Li, Lele Song, et al.
Cancer Discovery|April 9, 2024
St. Jude Survivorship Portal: Sharing and Analyzing Large Clinical and Genomic Datasets from Pediatric Cancer SurvivorsGavriel Y Matt, Edgar Sioson, Kyla Shelton, et al.
Cancer Discovery|January 21, 2026
Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal CancerWilliam C H Cross, Salpie Nowinski, George D Cresswell, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Cancer Discovery|February 6, 2026
Convergence for Inactivation of TGF-β Signaling Is a Common Feature of Advanced Pancreatic CancerJungeui Hong, Zachary A Kohutek, Haochen Zhang, et al.
Cancer Discovery|December 10, 2025
Trends in Childhood and Adolescent Cancer Incidence Rates in the United States between 2001 and 2022Meredith S Shiels, Anika T Haque, Rena R Jones, et al.
Pageof 427

Showing results (941-950 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Cancer Discovery|June 3, 2024
When Lightning Strikes Twice: Routes to Second Malignancies in Young PatientsClarissa N Pacyna, Jyoti Nangalia
Cancer Discovery|June 13, 2024
Tumor Promoters and Opportunities for Molecular Cancer PreventionWilliam Hill, Clare E Weeden, Charles Swanton
Cancer Discovery|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer EvolutionIros Barozzi, Neil Slaven, Eleonora Canale, et al.
Cancer Discovery|April 24, 2024
Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene ExpressionYiman Liu, Qinglan Li, Lele Song, et al.
Cancer Discovery|April 9, 2024
St. Jude Survivorship Portal: Sharing and Analyzing Large Clinical and Genomic Datasets from Pediatric Cancer SurvivorsGavriel Y Matt, Edgar Sioson, Kyla Shelton, et al.
Cancer Discovery|January 21, 2026
Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal CancerWilliam C H Cross, Salpie Nowinski, George D Cresswell, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Cancer Discovery|February 6, 2026
Convergence for Inactivation of TGF-β Signaling Is a Common Feature of Advanced Pancreatic CancerJungeui Hong, Zachary A Kohutek, Haochen Zhang, et al.
Cancer Discovery|December 10, 2025
Trends in Childhood and Adolescent Cancer Incidence Rates in the United States between 2001 and 2022Meredith S Shiels, Anika T Haque, Rena R Jones, et al.
Pageof 427